MTOR and cancer: This finding implies that tumors with a TME in which the JAK/STAT or TGF-β signaling pathways in immune cells engage in crosstalk and positive interactions with other cancer signaling pathways, such as the PI3K/mTOR or Wnt signaling pathways, are prone to recurrence.